Turn this list into pipeline.
Pharmaceutical Companies in Hull: 34 Active Firms (2026)
Pharmaceutical companies in Hull develop, manufacture, import or distribute regulated medicines across the surrounding metropolitan area.
Buying centres in this Hull cohort tend to sit with operations, quality, regulatory and procurement teams, rather than consumer marketing functions. Typical customers are business and public-sector buyers: medicine manufacturers needing local formulation or packaging support, wholesalers managing licensed supply, and healthcare-facing organisations that require controlled distribution and quality documentation. Engagements are usually site-level or account-based, with repeat compliance work, batch documentation, storage controls and service agreements carrying more weight than ad hoc sales. The natural fit is a local operator with regulated premises, a quality system and enough commercial activity to sustain audits, licence upkeep and wholesale or manufacturing relationships.
Read more
Hull has 34 actively trading pharmaceutical companies in this list, making the local market a small metropolitan cluster rather than a national-scale manufacturing base. The employment footprint is correspondingly modest: firms in the cohort report 89 employees between them, suggesting that much of the activity sits in small licensed operations, wholesale supply, specialist services and early commercial premises. That does not make the area irrelevant; regulated medicines work often depends on local sites with inspection history, named responsible staff and documented procedures. It does, however, mean researchers should expect a thin list, with only a limited number of sizeable employers visible in the area.
Human medicines activity in Hull sits under the same UK regime as the rest of the country. The MHRA sets standards, evaluates treatments, approves clinical trials, licenses medicines and oversees pharmacovigilance. Organisations that make, assemble or import human medicines need an MHRA manufacturer’s licence, good manufacturing practice compliance and inspection readiness; wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance. Marketing authorisation governs whether a medicine can be placed on the market, while NICE assessments can affect access to publicly funded demand. ABPI provides the main trade-body reference point for research-based pharmaceutical businesses.
Commercial development in Hull appears likely to be shaped more by licensing capacity, inspection readiness and distribution relationships than by lab-led discovery alone. The cohort tends to lean towards local regulated operations rather than large research campuses, so growth may come through add-on services, premises upgrades and closer links with healthcare supply chains. Compliance costs remain a gating factor: firms that can maintain quality systems, responsible-person cover and auditable storage conditions should be better placed than lighter-touch resellers. Consolidation also appears plausible where smaller operators struggle to carry licence, documentation and pharmacovigilance obligations alongside everyday trading.
34
Active firms
2026
1
Above £5M
reported turnover
8
Recent incorporations
since 2022
Key facts
About 2% of the trading cohort reports turnover above £5M (1 of 34 firms) — the rest sits below that revenue band.
23% of the cohort was incorporated since 2022 (8 firms), so a sizeable share is in its first few filing cycles.
The MHRA regulates UK human medicines, covering standards, clinical-trial approvals, medicine licensing and pharmacovigilance.
Organisations that make, assemble or import human medicines need an MHRA manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
UK businesses performed £9.0 billion of pharmaceutical R&D in 2022, equal to 0.36% of UK GDP and 18% of all UK business R&D.
UK pharmaceutical exports were £25.6 billion in 2023, placing the UK tenth among comparator countries.
Top Hull Pharmaceutical companies
TRAFALGAR PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
GMP Manufacturing Ltd
Trajectory
5y · 2019–NowFinancial sub-scores
Computed from 5 filingsProvides contract manufacturing, formulation research and development, and filling and packaging services for pharmaceutical and healthcare products. Offers bottle and tub filling, sterile filling,…
Serves B2B manufacturers in the pharmaceutical, medical device, cosmetic, food supplement and biocide sectors seeking outsourced manufacturing and packaging support.
Financial Health
HealthyHealthy
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures pharmaceutical formulations for global pharma companies, producing tablets, capsules, syrups, injectables, prefilled syringes and parenterals, as well as eye, ear and nasal drops. Also…
Serves B2B pharmaceutical companies globally, especially pharma leaders seeking manufacturing of formulations across multiple therapeutic segments and dosage forms. Targets buyers needing contract…
Financial Health
WeakWeak · 0% CAGR over 4y
Location
GMP Healthcare Ltd
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides quality, regulatory and compliance consultancy to pharmaceutical, biotechnology, biologics, and medical device companies. Services include GMP/GxP audits, regulatory inspection support,…
Serves pharmaceutical, biotech, biologics, ATMP, medical device and dietary supplement businesses, including manufacturers and life science teams responsible for GMP/GxP quality, regulatory…
Financial Health
StableStable
Location
City Health Pharmacy
Dispenses NHS and private prescriptions and provides community pharmacy services including prescription collection and delivery, flu and travel vaccinations, blood pressure checks, contraception…
Serves local residents and NHS patients in Hull and the East Riding, including prescription users, older adults, travellers needing vaccines, and people seeking pharmacy consultations, contraception…
Location
RUBICON TECHNICAL LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides regulatory affairs and technical consultancy for consumer health products including food supplements, medicines, cosmetics, medical devices and biocides. Services include quality management,…
Serves B2B consumer health and regulated product companies, including food supplement, food, pharmaceutical, cosmetic, medical device and biocide brands, from small firms to global healthcare…
Financial Health
WeakWeak · 0% CAGR over 4y
Location
GDP Compliance Ltd
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Pharmanuel Limited
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
StrongStrong · Hiring · 398% CAGR over 1y
Location
PHARMEDIX LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StrongStrong
Location
TD MANAGEMENT LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
StrongStrong · Growing · 0% CAGR over 2y
Location
WCC PHARMA LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides pharmaceutical products and related pharmaceutical services, operating as a pharmaceutical company supplying medicines and healthcare-related products to customers and organisations within…
Financial Health
WeakWeak · -5% CAGR over 3y
Location
Morrill Investments Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · Hiring · 15% CAGR over 4y
Location
Morrill Healthcare Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak
Location
EVC COMPOUNDING LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
DistressedDistressed · -90% CAGR over 2y
Location
Technostics Limited
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsProvides formulation and analytical testing services focused on the gastrointestinal tract. Uses in vitro and in vivo models to screen products, generate pre‑clinical evidence, and support dietary…
Serves B2B product development, formulation and regulatory/claims teams in pharmaceutical, nutraceutical and food companies, including blue-chip consumer healthcare brands.
Financial Health
WeakWeak · -33% CAGR over 4y
Location
BARSHAW LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · -68% CAGR over 4y
Location
Pinfold Pharmacy Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · Hiring · 10% CAGR over 3y
Location
TENNYSON HEALTHCARE LTD
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Unlock all 34 leads
Showing 18 of 34 — +16 more with verified decision-maker contacts, live data, and CRM sync.
How Hull Pharmaceutical companies work and how to sell to them
What they do
Revenue usually comes from regulated manufacturing, assembly, import, packaging, quality-control services or wholesale distribution, rather than consumer-facing medicine sales. Pricing tends to follow the operational unit of work: batch release support, formulation or packing runs, storage and distribution fees, documentation packages, or wholesale margin on licensed supply. Smaller Hull operators are likely to combine service revenue with repeat account work, especially where a customer needs local premises, controlled storage and inspection-ready processes. One firm in the cohort has moved past £5M revenue, so most suppliers selling into this segment should expect owner-managed or site-led budgets rather than large enterprise buying centres.
Who they sell to
Customers are usually regulated buyers with their own quality and procurement obligations: medicine manufacturers, wholesalers, healthcare-facing organisations and public-sector purchasers. Decision-makers tend to include operations leads, quality managers, regulatory staff, procurement teams and, in smaller firms, directors who carry commercial and compliance responsibility together. Sales cycles are rarely pure self-serve; most work is direct, evidence-led and relationship-based, with public-sector or healthcare-adjacent demand more likely to involve tendering, approved supplier checks or formal service agreements. Contract value depends less on user seats and more on volume, batch complexity, storage controls, audit burden and continuity of supply.
What they buy
Most Hull pharmaceutical firms tend to spend on systems and services that reduce inspection risk, protect margins and keep stock moving. Relevant software categories include quality management, document control, training records, inventory management, warehouse management, batch traceability, supplier qualification, pharmacovigilance workflow, accounting and CRM. They may also buy validation support, regulatory affairs advice, legal and insurance services, calibration, facilities maintenance, temperature monitoring, logistics, recruitment and outsourced finance. Sellers should expect evidence requirements around audit trails, access control, change management and service continuity; generic productivity claims are less useful than showing how a category supports good manufacturing practice, good distribution practice or licence upkeep.
Why and how to sell to them
Commercial intent often appears when a pharmaceutical operator changes premises, applies for or varies a licence, adds storage capacity, takes on a new manufacturing or wholesale relationship, or prepares for inspection. Hiring in quality, regulatory or operations roles can also indicate that informal processes are being replaced with documented controls. Pain points are usually mundane but commercially important: batch paperwork, supplier qualification, stock visibility, temperature excursions, audit preparation and keeping responsible staff covered. Outbound should therefore lead with risk reduction, faster evidence gathering and lower administrative load, while recognising that buyers may need validation notes, procurement documentation and implementation plans before committing.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Hull
Related directories
Frequently asked questions
How many pharmaceutical companies are there in Hull?
What counts as a pharmaceutical company in this list?
Which are the largest pharmaceutical companies in Hull?
What do pharmaceutical companies in Hull actually do?
How does Hull pharmaceutical compare internationally?
How is this list built and how fresh is the data?
How big are the typical pharmaceutical companies in Hull?
Are these mostly new or established pharmaceutical companies?
What SIC codes does this use?
What buying signals should I look for?
Push these 34 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.